Musculoskeletal Genomics Group

The focus of the Musculoskeletal Genomics Group (MSKG) is to combine information from statistical and molecular genetics studies to identify high potential drug targets for treating patients with osteoporosis.The group has a strong emphasis on multidisciplinary and collaborative research

Recent studies by the group provide evidence that mice and fish are valuable preclinical models for identifying cellular and genetic determinants of human skeletal health.

Current funding sources include the National Health and Medical Research Council (NHMRC), American Society of Bone and Mineral Research, and the Lions Dunning-Orlich Foundation.